http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Twist Bioscience (TWST) Selected as DNA Synthesis Provider for DNA Data Storage Project Under IARPA MIST Program
-
Twist Bioscience Selected as DNA Synthesis Provider for DNA Data Storage Project Under Intelligence Advanced Research Projects Activity (IARPA) Molecular Information Storage (MIST) Program
-
Twist Bioscience (TWST) Announces Strategic Collaboration With Schrodinger for Drug Discovery
-
Twist Bioscience Announces Strategic Collaboration With Schrödinger for Drug Discovery
-
Twist Bioscience Corporation (TWST) Promotes Patrick Weiss to COO
-
Twist Bioscience Promotes Patrick Weiss to Chief Operating Officer Setting Stage for Future Growth
-
Twist Bioscience Reports Fourth Quarter and Full Year Fiscal 2019 Financial Results
-
Twist Bioscience and Pandion Therapeutics Expand Antibody Optimization Collaboration
-
Twist Bioscience to Report Fiscal 2019 Fourth Quarter and Full Year Financial Results on Wednesday, December 11, 2019
-
Twist Bioscience Promotes Patrick J. Finn, Ph.D., to Chief Commercial Officer
-
Twist Bioscience to Present at Upcoming Investor Conferences
-
Twist Biopharma Implements Genedata Biologics to Advance Synthetic Biology-driven Antibody Discovery
-
Twist Bioscience to Provide Target Enrichment Products for MGI in Europe and Asia Pacific
-
Twist Bioscience Appoints Seasoned Life Sciences Industry Executive Nicolas M. Barthelemy to Board of Directors
-
Praesens Foundation, Institut Pasteur, Institut Pasteur de Dakar, University of Nebraska Medical Center, Twist Bioscience Consortium Win Prix Galien MedStartUp Award
-
Twist Bioscience Showcases Next-Generation Sequencing Products and Results at American Society for Human Genetics 2019 Annual Meeting
-
Twist Bioscience Showcases New Innovation Lab at SynBioBeta 2019
-
Twist Bioscience to Present at SynBioBeta 2019
-
Twist Bioscience to Present at Two Investor Conferences in September
-
Twist Bioscience Reports Third Quarter Fiscal 2019 Financial Results and Highlights Commercial and Operational Progress
-
Twist Bioscience Launches Long Oligos to Fuel Drug Development, DNA Data Storage and Gene Editing Research
-
Twist Bioscience Enhances DNA Storage Capabilities Through Agreement With Imagene SA
-
Twist Bioscience Launches Mouse Exome to Power Genetic Research
-
Twist Bioscience to Present at the Jefferies 2019 Global Healthcare Conference
-
Twist Bioscience Strengthens Board With Semiconductor and Storage Expert Nelson C. Chan
-
Collaboration of Four Biotech Companies Showcases High Throughput DNA Assembly Platform for Diverse Applications
-
Twist Bioscience to Present at the UBS Global Healthcare Conference
-
Twist Bioscience Reports Second Quarter Fiscal 2019 Financial Results and Highlights Commercial and Operational Progress
-
Twist Bioscience Announces Synthetic DNA Biosecurity Publication in Frontiers
-
Twist Bioscience to Report Fiscal 2019 Second Quarter Financial Results on Tuesday, April 30, 2019
-
Twist Bioscience and iGEM Partner to Provide Synthetic DNA for iGEM Competition and Registry
-
Twist Bioscience Announces Antibody Optimization Agreement with Pandion Therapeutics
-
Twist Bioscience Customized Libraries for Biologics Discovery Highlighted at PEGS Boston 2019
-
Twist Bioscience Adopts Battelle’s ThreatSEQ™ DNA Screening Web Service for Advanced Biosecurity
-
Twist Bioscience and LakePharma Form Strategic Collaboration to Provide Antibody Discovery and Development Services
-
Twist Bioscience Announces Presentations and User Group Meeting at PEGS Boston 2019
-
Twist Bioscience to Present at Cowen 39th Annual Healthcare Conference
-
Twist Bioscience Showcases Next-Generation Sequencing Solutions at the 2019 Advances in Genome Biology and Technology Meeting
-
Twist Bioscience Showcases Next-Generation Sequencing Solutions at the 2019 Advances in Genome Biology and Technology Meeting
-
Twist Bioscience Reports First Quarter Fiscal 2019 Financial Results and Highlights Commercial and Operational Progress
-
Twist Bioscience Announces Appointment of Martin Kunz as Senior Vice President, Operations
-
Twist Bioscience Chief Technology Officer Presented at Praesens Foundation Future Health Threats Initiative 2019
-
Twist Bioscience to Report Fiscal 2019 First Quarter Financial Results on Thursday, February 7, 2019
-
Twist Bioscience Receives ISO 13485:2016 and 9001:2015 Certifications of its Quality Management Systems for NGS Target Enrichment Panels
-
Twist Bioscience Enhances Genes Product Offering with Longer Genes and Offers Access to Its Application Programming Interface
-
Twist Bioscience to Present at the 37th Annual J.P. Morgan Healthcare Conference
-
Twist Bioscience Reports Fiscal 2018 Fourth Quarter and Full Year Financial Results and Highlights Commercial and Operational Progress
-
Twist Bioscience to Report Fiscal 2018 Fourth Quarter and Full Year Financial Results on Wednesday, December 19, 2018
-
Twist Bioscience to Present at the Evercore ISI HealthCONx Conference
-
Twist Bioscience Appoints Experienced Technology Executive Jan Johannessen to Board of Directors

